Return to Course LibraryCE Information

RELEASE DATE:
May 1, 2017

EXPIRATION DATE:
June 1, 2021


 

FACULTY

 

Alejandro Tejerina, MD
Director of Breast Imaging
Breast Pathology Center of Madrid
(Centro de Patología de la Mama – Fundación Tejerina)
Professor of Radiology and Breast Imaging
Chair of Breast Disease, Complutense University – Tejerina Foundation
Madrid, Spain

 

 

 

Equipment Requirements
PC: Win7/Win8, Pentium processor or faster, at least 2GB RAM, Internet Explorer version 10/11, Mozilla FireFox version 33.0.

MAC: OS version 10.8/10.9, Intel processor, at least 2GB RAM, Safari version 6.2, FireFox 33.0

A free one-hour archived webinar for radiologists, radiologic technologists, and other healthcare providers who manage patients with breast disease

Recording of a live webinar presented on April 19, 2017 available with closed captioning.
 

IMPORTANT NOTE: This course expires June 1, 2021

If you want credit, this course must be completed (i.e. view course content PDF file), pass the posttest, AND print the certificate)
by no later than 5PM Eastern Standard Time on May 31, 2021

Please note, after this course has expired, no aspect of the course will be accessible, including the course material.

Format: Archived Webinar
Credit: 1.0 AMA PRA Category 1
Credit: 1.0 ARRT Category A
Tuition: none

Course Overview
Given its exquisite ability to pinpoint a lesion, stereotactic breast biopsy remains a reliable and accurate means for sampling and diagnosis of mammographically-detected breast lesions. Breast stereotaxis offers obvious benefits to both patient and practitioner compared to needle wire localization and open surgical biopsy. Given the advent of 3D image-guided prone stereotaxis, breast imagers and interventionalists may now add another minimally invasive, safe, and accurate biopsy technique to their portfolio of image-guided breast biopsy options.

Educational Objectives
After completing this activity, the participant should be better able to:

  • Describe how the addition of 3D mammography to current practice can introduce new challenges that can be solved with tomosynthesis-directed biopsy
  • Explain the mechanics of 3D image-guided biopsy with tomosynthesis and how to safely and effectively sample the lesion(s) of interest
  • Discuss potential complications and challenges of 3D image-guided biopsy and compare upright tomosynthesis-directed biopsy to prone techniques

Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live event and e-learning materials. For more information go to
https://www.ama-assn.org/education/uemseaccme-cme-credit-recognition .

Radiologic Technologist Continuing Education
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.

How to Register and Participate in the Webinar
There are no fees or prerequisites to participate in this program. Estimated time to complete this activity is one hour.

  • Click ENROLL NOW, CONTINUE, CONFIRM ORDER, and ACCESS COURSE NOW.
  • Click on the blue link. Complete the precourse questions and SUBMIT.
  • Click on the blue link again to view the recording.

How to Receive a Credit Certificate
Your certificate of credit will remain in your account at www.icpme.us as a permanent record of your participation.

  • Log-in to your account at www.icpme.us
  • View the entire educational activity session. At the conclusion of the lecture, close the Vimeo window.
  • Return to the course in your account at www.icpme.us.
  • From the COURSE HOME page, click the button for POSTTEST and for EVALUATION.
  • A passing grade of at least 75% is required to receive credit. You may take the test up to three times.
  • Upon receipt of a passing grade, you will be able to print a certificate of credit from your account at www.icpme.us
Faculty
After receiving his bachelor degree in medicine at Complutense University of Madrid, Dr. Tejerina completed his medical and specialty education in radiology and breast imaging at La Princesa University Hospital of Madrid, Virgen de Arrixaca University Hospital of Murcia, and Jiménez Diaz Foundation-University Hospital of Madrid. Additional training in 3D mammography was acquired at King’s College Hospital in London.

Dr. Tejerina has extensive imaging experience in full-field digital mammography, digital breast tomosynthesis, breast ultrasound, and breast MRI, as well as image-guided biopsy for each of these modalities. He is a member of the Spanish Medical Radiology Society, the Spanish Breast Imaging Society, and the Spanish Senology and Breast Pathology Society.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

The faculty has reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Alejandro Tejerina, MD, has NO conflicts to report.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Trace Hutchison, PharmD    Victoria Phoenix, BS
Linda McLean, MS      Jan Schultz, MSN, RN, CHCP
Samantha Mattiucci, PharmD, CHCP        Judi Smelker-Mitchek, MBA, MSN, RN

Disclosure of Unlabled Use
This educational activity may contain discussion of published and/or investigational uses of products and devices that are not indicated by the U.S. Federal Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Questions
For questions regarding this program, please contact ICPME at information@icpmed.com.

Jointly provided by

               
 
  This activity is supported by an independent educational grant from Hologic, Inc.

 

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.